Transcode Therapeutics, Inc. SEC filings RNAZ
Transcode Therapeutics, Inc. has 324 filings in SEC EDGAR's recent list, going back to Dec 18, 2020. Its latest annual report, Form ARS, was filed on Jun 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 20, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 17, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Other events
|
Jul 2, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Other events
|
Jun 3, 2026 | Jun 3, 2026 |
| 8-K | Current report | Jun 1, 2026 | May 29, 2026 |
| 8-K/A |
Amended current report
Listing notice
|
May 26, 2026 | May 19, 2026 |
| 8-K |
Current report
Listing notice
|
May 22, 2026 | May 19, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Apr 7, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Mar 3, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K/A |
Amended current report
Other events
|
Dec 23, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 22, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 11, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 27, 2025 | Oct 27, 2025 |
| 8-K/A |
Amended current report
Material agreement
|
Oct 17, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Other events
|
Oct 14, 2025 | Oct 13, 2025 |
| 8-K/A |
Amended current report
Material agreement
|
Oct 8, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 8, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 2, 2025 | Aug 29, 2025 |
| 8-K | Current report | Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Listing notice
|
May 7, 2025 | May 6, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
May 2, 2025 | May 2, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Apr 21, 2025 | Apr 21, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 25, 2025 | Mar 23, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Other events
|
Dec 20, 2024 | Dec 18, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 2, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Nov 29, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 25, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 6, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 27, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Other events
|
Aug 28, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 16, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 24, 2024 | Jul 22, 2024 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Other events
|
Jun 7, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Other events
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Listing notice
|
May 10, 2024 | May 7, 2024 |
| 8-K | Current report | Apr 23, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 5, 2024 | Apr 3, 2024 |
| 8-K |
Current report
Other events
|
Jan 31, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 22, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Results of operations, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jan 16, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 8, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 4, 2023 | Nov 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 9, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 27, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Other events
|
Oct 24, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 28, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Other events
|
Aug 24, 2023 | Aug 23, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 4, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 28, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Material agreement, Listing notice, Other events
|
Jun 8, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
May 22, 2023 | May 19, 2023 |
| 8-K |
Current report
Officer or director change
|
May 19, 2023 | May 18, 2023 |
| 8-K |
Current report
Listing notice
|
May 18, 2023 | May 16, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 14, 2023 | Apr 13, 2023 |
| 8-K | Current report | Mar 31, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Unregistered share sale, Other events
|
Feb 17, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 1, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 9, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 30, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Other events
|
Aug 3, 2022 | Jul 29, 2022 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 23, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 8-K |
Current report
Other events
|
Sep 30, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 23, 2021 | Aug 23, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 13, 2021 | Jul 13, 2021 |
Showing 88 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RNAZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829635
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.